These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7308587)

  • 1. Long-term continuous intraperitoneal insulin infusion with an implanted remote-controlled insulin infusion device.
    Irsigler K; Kritz H; Hagmüller G; Franetzki M; Prestele K; Thurow H; Geisen K
    Diabetes; 1981 Dec; 30(12):1072-5. PubMed ID: 7308587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total implantation of a remotely controlled insulin minipump in a human insulin-dependent diabetic.
    Selam JL; Slingeneyer A; Chaptal PA; Franetzki M; Prestele K; Mirouze J
    Artif Organs; 1982 Aug; 6(3):315-9. PubMed ID: 6758737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of programmable infusion pumps for insulin delivery in type I diabetic patients.
    Walter H; Günther A; Kronski D; Flaschenträger T; Mehnert H
    Klin Wochenschr; 1989 Jun; 67(11):583-7. PubMed ID: 2747136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
    Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year trial of a remote-controlled implantable insulin infusion system in type I diabetic patients. Point Study Group.
    Lancet; 1988 Oct; 2(8616):866-9. PubMed ID: 2902316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin delivery by implanted pumps: one-year trial with programmable infusion systems (the Point Study).
    Walter H
    Int J Artif Organs; 1989 Dec; 12(12):793-8. PubMed ID: 2693370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
    Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB
    Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of a 7 year case-control study of continuous intraperitoneal insulin infusion and subcutaneous insulin therapy among patients with poorly controlled type 1 diabetes mellitus: favourable effects on hypoglycaemic episodes.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Bilo HJ; Kleefstra N
    Diabetes Res Clin Pract; 2014 Nov; 106(2):256-63. PubMed ID: 25305134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal insulin absorption after long-term intraperitoneal insulin therapy.
    Scavini M; Pincelli A; Petrella G; Galimberti G; Zager PG; Torri M; Pozza G
    Diabetes Care; 1995 Jan; 18(1):56-9. PubMed ID: 7698048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with insulin analog lispro in IDDM with delayed absorption of subcutaneously applied human regular insulin and complicated intraperitoneal insulin infusion. A case report.
    Meier M; Brand J; Standl E; Schnell O
    Diabetes Care; 1998 Jul; 21(7):1044-5. PubMed ID: 9653592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.
    Olsen CL; Turner DS; Iravani M; Waxman K; Selam JL; Charles MA
    Diabetes Care; 1995 Jan; 18(1):70-6. PubMed ID: 7698051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preprogrammed insulin infusion with a portable pump system.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
    Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A portable infusion pump, programmable with 16 rates.
    Bojsen J; Kølendorf K; Haslev F; Jørgensen K
    Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmable open-loop micropump insulin delivery system.
    Clemens AH
    Diabetes Care; 1980; 3(2):359-61. PubMed ID: 6993153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1985 Mar; 290(6471):811-5. PubMed ID: 3919804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients.
    Clergeau A; Parienti JJ; Reznik Y; Clergeau D; Seguin A; Valette X; du Cheyron D; Joubert M
    Diabetes Technol Ther; 2017 Feb; 19(2):115-123. PubMed ID: 28118045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.